Background illustration for clinical trials search

Paid Clinical Trials San Francisco

Discover 2,262 paid clinical trials in San Francisco, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

for
Melanoma (Skin Cancer), Melanoma Stage IIIB-IV,
Location: San Francisco CA, Stanford CA, Newport Beach CA,
Sponsor: Linnaeus Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06624644

Phase 2, Phase 3, Recruiting

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

for
Relapsed AL Amyloidosis, Refractory AL Amyloidosis,
Location: San Francisco CA, Phoenix AZ, Calgary, Rochester MN,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07081646

Phase 1, Phase 2, Recruiting

Preoperative Fasting vs. Not Fasting in Critically Ill Patients

for
Critical Illness, Surgical Procedure, Unspecified,
Location: San Francisco CA, Palo Alto CA, Minneapolis MN,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT06751043

Recruiting

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

for
Acute Myeloid Leukemia
Location: San Francisco CA, Los Angeles CA, Kansas City KS,
Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland

Sex: All

Age: 18+

Code: NCT07223814

Phase 3, Recruiting

Effect of Magnesium on Neuromonitoring

for
Spine, Pain, Spine Surgery, Spine Surgery With Neuromonitoring,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT06975072

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

for
Rheumatoid Arthritis (RA), Hidradenitis Suppurativa (HS)
Location: San Francisco CA, Stanford CA, Aurora CO, Chicago IL,
Sponsor: Sonoma Biotherapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07123038

Recruiting

Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study

for
Moderate Aortic Valve Stenosis
Location: San Francisco CA, Beverly Hills CA, Pasadena CA,
Sponsor: Kardigan, Inc.

Sex: All

Age: 50+

Code: NCT07001800

Phase 2, Phase 3, Recruiting

Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

for
Aneurysm, Stroke, Vasculitis, Tumor Necrosis Factor-alpha
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT02638701

Phase 1, Phase 2, Recruiting

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

for
Primary Membranous Nephropathy
Location: San Francisco CA, Stanford CA, Fresno CA,
Sponsor: Biogen

Sex: All

Age: 18 - 70+

Code: NCT06962800

Phase 3, Recruiting

Gauging Outcomes of Total Milk Ingestion on Lipid and gControl

for
Heart Diseases, Cardiovascular Disease
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT07087184

Recruiting

A Study to Assess the Effects of Zigakibart on IgA Nephropathy.

for
Immunoglobulin A Nephropathy (IgAN)
Location: San Francisco CA, Denver CO, Edina MN, Iowa City IA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07146906

Phase 2, Recruiting

A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumors That Are MTAP Deficient
Location: San Francisco CA, Portland OR, Pittsburgh PA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06130553

Phase 1, Phase 2, Recruiting

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

for
Delayed Graft Function, DGF, Kidney Transplant
Location: San Francisco CA, Stanford CA, Los Angeles CA,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06830798

Phase 3, Recruiting

Primary Tumor Research and Outcomes Network

for
Spinal Column Tumor
Location: San Francisco CA, Vancouver, Rochester MN, Houston TX,
Sponsor: AO Innovation Translation Center

Sex: All

Age: 0+

Code: NCT02790983

Recruiting

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

for
Obstructive Hypertrophic Cardiomyopathy
Location: San Francisco CA, Palo Alto CA, Los Angeles CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT05489705

Recruiting

Tranexamic Acid to Reduce Blood Loss in Spine Surgery

for
Spinal Injuries, Spinal Deformity
Location: San Francisco CA, Louisville KY, Durham NC, New York NY
Sponsor: Columbia University

Sex: All

Age: 18 - 70+

Code: NCT02314988

Phase 2, Phase 3, Recruiting

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

for
Rheumatic Joint Disease
Location: San Francisco CA, Palo Alto CA, Los Angeles CA,
Sponsor: Duke University

Sex: All

Age: 0 - 21

Code: NCT02418442

Recruiting

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia,
Location: San Francisco CA, Oakland CA, Santa Clara CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554406

Phase 2, Recruiting

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

for
B-cell Acute Lymphoblastic Leukemia
Location: San Francisco CA, Oakland CA, Los Angeles CA, Duarte CA,
Sponsor: Pediatric Transplantation & Cellular Therapy Consortium

Sex: All

Age: 1 - 25

Code: NCT03509961

Phase 2, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: San Francisco CA, Stanford CA, Santa Barbara CA,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase 3, Recruiting